Emergent Biosolutions: Fourth Quarter Financial Overview
Emergent Biosolutions Reports Fourth Quarter Financial Results
Emergent Biosolutions Inc., headquartered in Gaithersburg, Maryland, announced on Thursday that it recorded a net loss of $54.6 million for the fourth quarter.
The company stated that this equates to a loss of $1.04 per share. After excluding one-time expenses, the adjusted loss was 43 cents per share.
During the same quarter, Emergent Biosolutions generated $148.7 million in revenue.
Looking at the full year, the company achieved a net income of $52.6 million, or 93 cents per share, with total annual revenue reaching $742.9 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Here’s Why Hyperliquid Traders Must Brace for $29 Million Liquidation Threat

Next 100x Crypto? Top 5 Coins That Could Rally 300x If Momentum Ignites

Oil prices rise in early market trading after attacks in Middle East disrupt global energy supply
